Chemoinformaics analysis of ALIZARIN 1-METHYL ETHER
| Molecular Weight | 254.241 | nRot | 1 |
| Heavy Atom Molecular Weight | 244.161 | nRig | 18 |
| Exact Molecular Weight | 254.058 | nRing | 3 |
| Solubility: LogS | -4.792 | nHRing | 0 |
| Solubility: LogP | 3.084 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 29 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 2 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 12 |
| nHA | 4 | APOL | 34.9259 |
| nHD | 1 | BPOL | 13.5041 |
| QED | 0.723 |
| Synth | 2.007 |
| Natural Product Likeliness | 1.124 |
| NR-PPAR-gamma | 0.679 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.824 |
| Pgp-sub | 0 |
| HIA | 0.007 |
| CACO-2 | -4.754 |
| MDCK | 0.0000173 |
| BBB | 0.264 |
| PPB | 0.985563 |
| VDSS | 0.449 |
| FU | 0.016791 |
| CYP1A2-inh | 0.968 |
| CYP1A2-sub | 0.699 |
| CYP2c19-inh | 0.451 |
| CYP2c19-sub | 0.068 |
| CYP2c9-inh | 0.651 |
| CYP2c9-sub | 0.646 |
| CYP2d6-inh | 0.379 |
| CYP2d6-sub | 0.302 |
| CYP3a4-inh | 0.668 |
| CYP3a4-sub | 0.196 |
| CL | 6.287 |
| T12 | 0.196 |
| hERG | 0.042 |
| Ames | 0.855 |
| ROA | 0.219 |
| SkinSen | 0.126 |
| Carcinogencity | 0.943 |
| EI | 0.975 |
| Respiratory | 0.062 |
| NR-Aromatase | 0.647 |
| Antiviral | Yes |
| Prediction | 0.752603 |